3628 results for «2083»
3628 results
Align for the future with the novel balloon expandable Myval transcatheter heart valve series
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore expert insights into best-in-class TAVI practices, from pre-procedural imaging and treatment strategy to procedural tips and post-procedural management. Learn from a compelling case study of an 88-year-old male patient with severe symptomatic aortic stenosis treated with the innovative MyVal Octapro THV....
Unlocking the potential of mitral and tricuspid valves clipping
24 Nov 2024 – From PCR London Valves 2024
This session examines two compelling cases: a 78-year-old woman with paroxysmal atrial fibrillation, chest trauma, an osteoporotic sternum fracture, and NYHA II exertional dyspnoea, and an 82-year-old man with chronic three-vessel coronary artery disease, bradycardic AF, peripheral arterial disease, spinal stenosis, and chronic kidney disease. Through...
Insights from the top late-breaking trials at PCR London Valves 2024
24 Nov 2024 – From PCR London Valves 2024
Looking to stay ahead in transcatheter valve therapies? Don't miss out this video showcasing the most impactful late-breaking trials from PCR London Valves 2024.
Discover pivotal findings, including one-year results comparing two balloon-expandable TAVI valves, outcomes of the TRISCEND II trial for tricuspid regurgitation and groundbreaking insights...
TAVI in women - Recent trials and current understanding
25 Nov 2024 – From PCR London Valves 2024
Looking to learn more about gender-based differences in the presentation and management of aortic stenosis? Dont' miss this video on the specifics of TAVI in women!
You'll discover how aortic stenosis presents uniquely in female patients, review the latest data on TAVI outcomes in women, and gain...
Featured cases - Transcatheter interventions in cardiogenic shock
25 Nov 2024 – From PCR London Valves 2024
Witness the exceptional management of transcatheter interventions in cardiogenic shock, as showcased in this captivating session featuring selected PCR London Valves 2024 clinical cases. Explore innovative techniques, including flexible nitinol clip repair for ischemic mitral regurgitation, TAVI for acute heart failure, and the use of ECMO...
Transcatheter mitral valve replacement - Are we there yet?
25 Nov 2024 – From PCR London Valves 2024
Are we ready to embrace transcatheter mitral valve replacement (TMVR) as the next big step in mitral interventions? Find out in this must-watch video!
Discover the key anatomical factors that favor TMVR over TEER, get acquainted with cutting-edge TMVR platforms like Tioga, Cephea and Intrepid, and master...
Rapid-Fire - Tricuspid TEER
25 Nov 2024 – From PCR London Valves 2024
Discover a rapid-fire session showcasing selected PCR London Valves 2024 clinical cases focused on Tricuspid Transcatheter Edge-to-Edge Repair (T-TEER). Explore a range of complications and innovative solutions, such as cardiogenic shock, single leaflet device attachment, and increased transvalvular gradients. Gain valuable insights into the challenges and...
Prevention, recognition and effective complication management during transcatheter valve interventions
25 Nov 2024 – From PCR London Valves 2024
This session delves into the critical topic of preventing, recognizing, and effectively managing complications during transcatheter valve interventions. Gain insights on anticipating potential complications, preparing the team, and translating this knowledge into everyday clinical practice. Through case-based discussions, learn how to react and work collaboratively when...
Mind the gap! - What's missing in the field of transcatheter valve interventions
25 Nov 2024 – From PCR London Valves 2024
Explore the key requirements for broadly adopting Transcatheter Mitral Valve Repair (TMVR), examine the challenges of Left Ventricular Outflow Tract Obstruction in Mitral Valve Replacement (MVR), and identify the additional tools needed for effective mitral valve repair. This session will provide a comprehensive assessment of the...
Rapid-Fire - Rare and unusual (Part 2)
25 Nov 2024 – From PCR London Valves 2024
Delve into a series of rare and unusual cases selected from the PCR London Valves 2024 Clinical Cases submissions. Explore a wide range of complex interventional scenarios, including edge-to-edge strategy failure, a challenging case of LAA occlusion, a large aortic pseudoaneurysm, and more. This rapid-fire session...
Mind the gap! - What's missing in the field of transcatheter aortic valve interventions
25 Nov 2024 – From PCR London Valves 2024
This session aims to uncover the hidden gaps in the field of transcatheter aortic valve interventions (TAVI). Explore strategies for optimizing hemodynamics, durability, flow, and frame expansion post-TAVI. Review current knowledge and emerging approaches to improve hemodynamic performance, device durability, and flow dynamics after TAVI. Discuss...
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Contemporary techniques for TAV-in-SAV interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...
Valve-in-Valve
17 Feb 2024 – From PCR Tokyo Valves 2024
Discover various compelling cases of valve-in-valve interventions in this session: such as TAVI for a structural valve deterioration with winding snake-like aorta, the uses of tomography-fluoroscopy fusion imaging in bioprosthetic aortic valve cracking, and more!
Learn the evidence - Lifetime management of aortic stenosis therapy with self-expandable valve
17 Feb 2024 – From PCR Tokyo Valves 2024
In this dedicated session on aortic stenosis management, gain insights into interpreting the 10-year outcomes of the NOTION trial, the 4-year outcomes of the Evolut Low Risk trial, and the key findings from the CANNULATE TAVR study, and discuss the issue of long-term device durability, draw comparisons...
TAVI and future coronary access - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 81-year-old woman, with a history of breast cancer surgery, stroke, and lymphoma remission, presented a severe symptomatic aortic stenosis associated with a suspicion of right coronary artery disease on the CT. The operators decided to perform TAVI first and then control the RCA by angiography...
TAV-in-TAV interventions: a new frontier in TAVI
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore the distinctions between TAV-in-TAV and TAV-in-SAV, learn more about the challenges posed by heterogeneity and variability in TAV redo procedures, gain insights into the unified terminology of TAV designs, and uncover how step-by-step CT analysis facilitates comprehensive assessments and post Redo-TAV solutions, drawing from detailed...
Heart Team in action: managing complex cases together
17 Feb 2024 – From PCR Tokyo Valves 2024
In this group discussion, several heart teams present their work on complex cases of tricuspid valve interventions and explore the results of their collaboration in order to figure out adequate management for invasive treatments.
PCR Tokyo Valves 2024 Closing Ceremony
18 Feb 2024 – From PCR Tokyo Valves 2024
The closing ceremony of this 2024 edition of PCR Tokyo Valves is an opportunity to present the finalists and then to award the prizes to the winners of the best clinical case and best scientific abstract, before thanking all those involved in making the 3-day Course...
The role of WATCHMAN therapy in optimising results and future perspectives
17 Feb 2024 – From PCR Tokyo Valves 2024
This special session sponsored by Boston Scientific will help you understand the latest status and the value of WATCHMAN therapy, as well as learning about future perspectives of LAA closure by new WATCHMAN FLX pro.